carprofen has been researched along with 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argyle, DJ; Argyle, SA; Kamida, A; Morrison, KO; Pang, LY | 1 |
| Becskei, C; Chaudhry, Y; Payne-Johnson, M; Stegemann, MR | 1 |
1 trial(s) available for carprofen and 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide
| Article | Year |
|---|---|
Comparative efficacy and safety of mavacoxib and carprofen in the treatment of canine osteoarthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dog Diseases; Dogs; Double-Blind Method; Female; Inflammation; Male; Osteoarthritis; Pain; Pyrazoles; Treatment Outcome | 2015 |
1 other study(ies) available for carprofen and 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide
| Article | Year |
|---|---|
The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro.
Topics: Animals; Antineoplastic Agents; Carbazoles; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Dogs; Neoplasm Invasiveness; Neoplastic Stem Cells; Pyrazoles | 2014 |